Naltrexone [ReVia] will be fully funded by New Zealand's drug-funding agency, Pharmac, from 1 June 2004, for patients with alcoholism.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 453, 2004-05-22 , pp. 11-11(1)

Publisher: Adis International

Keywords: Alcoholism, treatment; Naltrexone, therapeutic use; Reimbursement

Document Type: Short communication

Links for this article

http://www.ingentaconnect.com/adis/peon/2004/00000001/00000453/art00028
http://openurl.ingenta.com/content?genre=article&issn=1173-5503&volume=1&issue=453&spage=11&epage=11